This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tersera Therapeutics LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lonnie Brent: Advancing Care for Neuroendocrine Tumor Patients
Introduction
Lonnie Brent is an inventor based in Deerfield, Illinois. His patent work addresses treatment approaches intended to reduce the risk of carcinoid heart disease in patients with neuroendocrine tumors.
Latest Patents
Brent is associated with 1 patent, titled “Methods of Reducing the Likelihood of Carcinoid Heart Disease in Patients with Neuroendocrine Tumors.” The patent describes methods involving telotristat ethyl for patients with newly diagnosed neuroendocrine tumors, patients showing early signs of carcinoid heart disease who have not undergone heart valve replacement, and patients who have recently had a valve replacement. The described treatment aims to reduce the development of carcinoid heart disease and improve clinical outcomes.
Career Highlights
Brent is associated with Tersera Therapeutics LLC. His patent focuses on potential treatment strategies for different stages of neuroendocrine tumor care and related cardiac risks.
Collaborations
Brent’s listed coworker is Janine North. Their professional association is connected with work at Tersera Therapeutics LLC.
Conclusion
Lonnie Brent’s patent describes the use of telotristat ethyl as a treatment approach intended to help reduce carcinoid heart disease risk and improve outcomes for patients with neuroendocrine tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile